Legal Spend Management Software Provider Apperio Names Dominic Aelberry as CRO
Customer Success to be a Key Focus of the Newly Created Executive Position; Strategic Hire Builds on Momentum Following a $7 Million Growth Round and Major Business Partnership
Featured interview: Kheiron Medical CEO Dr. Peter Kecskemethy
In the ongoing fight against breast cancer, the American Cancer Society notes that screening mammograms miss around one in eight breast cancers. Now one London-based startup is looking to change that with artificial intelligence. Founded in 2016, Kheiron Medical Technologies is helping radiologists detect breast cancers earlier with its AI screening product. Joining Julia to discuss is Kheiron CEO Dr. Peter Kecskemethy.
Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery
Targeted protein degradation discovery programme to harness artificial intelligence to identify new E3 Ligase-based therapeutic strategies
Dr. David Brown: How Viagra Opened The Doors To Machine Learning Innovation
Throughout his storied career, Dr. David Brown has made significant contributions to medical research within the pharmaceutical industry, but perhaps his most famous innovation came about through a chance observation when the angina medication he was working on had unexpected applications.
OpenAI and Faculty partner to open generative AI use cases
OpenAI, the developer of ChatGPT, has enlisted UK start-up Faculty to help businesses generate new value opportunities with generative AI
East of England women entrepreneurs win Innovate UK awards
Four East of England women entrepreneurs – three of them from Cambridgeshire – have each won Innovate UK Women in Innovation Awards to scale development of novel solutions to major social, environmental and economic challenges.
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification With AI-driven Drug Discovery Platform
Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.
Rarecan eyes up to £3m investment this year as cancer platform targets rapidly growing market
The Hexham-based start-up is on the hunt for a lead investor to take it into its next funding round
Five Alarm Bio raises £500k to strengthen Cambridge’s anti-ageing hand
Cambridge’s hand in the field of anti-ageing science and technology has been strengthened further with a £500k seed investment round for Five Alarm Bio (FAB).
New Featurespace technology zaps the ‘Scamdemic’
The noose has tightened around the necks of online fraudsters after Featurespace unveiled powerful new technology to counter the current Scamdemic – a crippling upsurge in financial crime costing people trillions worldwide.
Arvest Bank launches loan offering leveraging Thought Machine’s solution
US-based Arvest Bank has launched a new credit offering using Thought Machine’s cloud-native core banking technology.
CyberSmart secures £13m for SME cybersecurity software
London-based startup CyberSmart has secured £12.75m in Series B funding for its cybersecurity and insurance products for SMEs.
Paragraf manufacturing facility to massively boost production
Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, has taken possession of a second manufacturing site in Huntingdon, Cambridgeshire.
Cambridge AI helps drive ‘Bio Revolution’ to reap harvest in India and Africa
Eagle Genomics, an AI-driven company in Cambridge, has joined forces with Indian scientific research hothouse ICRISAT at the intersection of life science and data science to help solve urgent global challenges in food security, nutrition, and agriculture.
Interview with Zero Gravity's CEO: 'Tech driven, human powered'
With Bdaily’s Innovation week now in full swing, we hear from Zero Gravity’s founder and CEO Joe Seddon. From humble beginnings in West Yorkshire, Joe made his way to Oxford University, upon graduating he founded Zero Gravity, where his innovative ideas and determination would see him become one of Forbes’ 30 under 30.
Top clinicians help Boutros Bear fight chronic pain and boost staff productivity
Cambridge-based digital health provider Boutros Bear has appointed two of the UK’s leading clinicians and signed its first national partnership with manufacturing body Make UK. The moves follow a sustained period of investment and expansion.
52 North Health makes history as first Macmillan investment
52 North Health has made history by becoming the first-ever investment for Macmillan’s new £3.5m Innovation Impact investment portfolio.
![Plain English: What the partnership between Apperio and Aderant means for law firms and corporate counsel [Q&A]](https://images.squarespace-cdn.com/content/v1/67c981a3f9bc24084b3040d7/1741259208989-YRNVZ7MMPDLW79AW6HD5/apperio+and+racing.jpg)
Plain English: What the partnership between Apperio and Aderant means for law firms and corporate counsel [Q&A]
The partnership between Apperio and Aderant will benefit both law firms and corporate counsel alike, says Apperio Founder and CEO Nicholas d’Adhemar in this Q&A.
Seneca Partners completes investment into delivery software firm HubBox
Seneca Partners (“Seneca”), the specialist SME investment business based in the North West, is delighted to announce it has backed HubBox – the retail technology company providing local pick-up solutions for retailers and shoppers – with investment from the Seneca EIS Portfolio Fund and the Seneca Growth Capital VCT.
Bell Joins Rovco as Head of Geoscience
Rovco strengthened its senior leadership team with the appointment of Graham Bell as Head of Geoscience.